Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AdaptHealth (AHCO) EBITDA (2018 - 2025)

Historic EBITDA for AdaptHealth (AHCO) over the last 8 years, with Q3 2025 value amounting to $154.3 million.

  • AdaptHealth's EBITDA rose 379.52% to $154.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $615.8 million, marking a year-over-year increase of 11006.17%. This contributed to the annual value of $606.8 million for FY2024, which is 34449.22% up from last year.
  • AdaptHealth's EBITDA amounted to $154.3 million in Q3 2025, which was up 379.52% from $166.5 million recorded in Q2 2025.
  • AdaptHealth's 5-year EBITDA high stood at $182.7 million for Q4 2024, and its period low was -$370.7 million during Q3 2023.
  • Over the past 5 years, AdaptHealth's median EBITDA value was $134.1 million (recorded in 2021), while the average stood at $91.1 million.
  • In the last 5 years, AdaptHealth's EBITDA skyrocketed by 92126.86% in 2021 and then plummeted by 37391.11% in 2023.
  • Quarter analysis of 5 years shows AdaptHealth's EBITDA stood at $134.1 million in 2021, then fell by 11.22% to $119.0 million in 2022, then plummeted by 210.06% to -$131.0 million in 2023, then skyrocketed by 239.44% to $182.7 million in 2024, then decreased by 15.51% to $154.3 million in 2025.
  • Its last three reported values are $154.3 million in Q3 2025, $166.5 million for Q2 2025, and $112.4 million during Q1 2025.